Auflistung nach Autor "Forschner, Andrea Lydia"

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start

Seith, Ferdinand Frederic; Schmidt, Holger; Pfannenberg, Christina; Nikolaou, Konstantin; Garbe, Claus; Schwenzer, Nina; Forschner, Andrea Lydia; Gückel, Brigitte; La Fougère, Christian Jean (2018)

Absolute and relative differential blood count predicts survival of AJCC stage I-II melanoma patients scheduled for sentinel lymph node biopsy

Wagner, Nikolaus B.; Luttermann, Felix; Gassenmaier, Maximilian; Forschner, Andrea Lydia; Leiter-Stöppke, Ulrike; Garbe, Claus; Eigentler, Thomas (2020)

Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?

Amaral, Teresa; Sinnberg, Tobias; Martus, Peter; Garbe, Claus; Forschner, Andrea Lydia (2020)

Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry

Amaral, Teresa; Flatz, Lukas; Thomas, Ioannis; Garbe, Claus; Eigentler, Thomas; Martus, Peter; Serna Higuita, Lina María; Forschner, Andrea Lydia; Leiter-Stöppke, Ulrike; Seeber, Tonia Olivia (2021)

Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma

Wölffer, Marcus Benedict Antonius; Flatz, Lukas; Martus, Peter; Forschner, Andrea Lydia; Schulze, Martin (2022)

Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours

Brenner, Ellen; Wieder, Thomas; Hilke, Franz Joachim; Simon, Nadine Maria; Schroeder, Christopher; Demidov, German; Fehrenbacher, Birgit; Schaller, Martin; Niessner, Heike; Sinnberg, Tobias; Zwirner, Stefan; Zender, Lars; Sonanini, Dominik; Eichner, Martin; Biskup, Saskia; Quintanilla-Martinez, Leticia; Kneilling, Manfred; Schörg, Barbara F.; Forschner, Andrea Lydia; Eigentler, Thomas; Böhm, Katharina; Braumüller, Heidi; Dauch, Daniel Alexander; Bauer, Jürgen; Döcker, Dennis Miklas; Pichler, Bernd; Röcken, Martin (2020)

Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive in vivo F-18-FDG-PET

Schwenck, Johannes Walter; Fiz, Francesco; Sonanini, Dominik; Martella, Manuela; Gonzalez Menendez, Irene; Seith, Ferdinand Frederic; Quintanilla-Martinez, Leticia; Garbe, Claus; Pfannenberg, Christina; Kneilling, Manfred; Schörg, Barbara F.; Forschner, Andrea Lydia; Eigentler, Thomas; Weide, Benjamin Matthias; Röcken, Martin; La Fougère, Christian Jean; Pichler, Bernd (2020)

Case report: Combined CDK4/6 and MEK inhibition in refractory CDKN2A and NRAS mutant melanoma

Forschner, Andrea Lydia; Sinnberg, Tobias; Decker-Mroz, Gabriele; Schroeder, Christopher; Reinert, Christian Philipp; Gatidis, Sergios; Bitzer, Michael; Eigentler, Thomas; Garbe, Claus; Niessner, Heike; Röcken, Martin; Roggia, Cristiana; Armeanu-Ebinger, Sorin; Rieß, Olaf; Mattern, Sven; Nann, Dominik; Bonzheim, Irina (2021)

Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience

Artzner, Christoph; Mossakowski, Oliver; Hefferman, Gerald; Grosse, Ulrich; Syha, Roland; Hoffmann, Rüdiger; Forschner, Andrea Lydia; Eigentler, Thomas; Grözinger, Gerd Christian (2019)

Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis

Forschner, Andrea Lydia; Weide, Benjamin Matthias; Garbe, Claus (2022)

Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors - Results of a Prospective Biomarker Study

Forschner, Andrea Lydia; Sinnberg, Tobias; Garbe, Claus (2020)

Clinical and prognostic value of tumor volumetric parameters in melanoma patients undergoing(18)F-FDG-PET/CT: a comparison with serologic markers of tumor burden and inflammation

Reinert, Christian Philipp; Gatidis, Sergios; Sekler, Julia; Pfannenberg, Christina; Nikolaou, Konstantin; Dittmann, Helmut; La Fougère, Christian Jean; Forschner, Andrea Lydia (2020)

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients

Forschner, Andrea Lydia (2018)

Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free Survival

Forschner, Andrea Lydia (2021)

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

Forschner, Andrea Lydia; Thomas, Ioannis; Garbe, Claus; Eigentler, Thomas (2016)

Dermatofluoroscopy diagnostics in different pigmented skin lesions: Strengths and weaknesses

Keim, Ulrike; Tampouri, Ioanna; Garbe, Claus; Forschner, Andrea Lydia; Spänkuch, Iris; Eigentler, Thomas; Weide, Benjamin Matthias (2020)

Dermatofluoroscopy Is Also for Redheads a Sensitive Method of Early Melanoma Detection

Forschner, Andrea Lydia (2020)

Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET/CT and PET/MRI Data

Vogel, Jonas; Hepp, Tobias; Pfannenberg, Christina; Schmidt, Holger; Nikolaou, Konstantin; Küstner, Thomas; Forschner, Andrea Lydia; Schwenzer, Nina; La Fougère, Christian Jean; Seith, Ferdinand Frederic (2022)

Diagnostic accuracy of dermatofluoroscopy in cutaneous melanoma detection: results of a prospective multicentre clinical study in 476 pigmented lesions

Forschner, Andrea Lydia; Keim, Ulrike; Spänkuch, Iris; Lomberg, Diana Jasmin; Weide, Benjamin Matthias; Tampouri, Ioanna; Eigentler, Thomas; Garbe, Claus (2018)

Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study

Forschner, Andrea Lydia; Leiter-Stöppke, Ulrike (2021)

Auflistung nach Autor "Forschner, Andrea Lydia"

Auflistung nach Autor "Forschner, Andrea Lydia"

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Hilfe & Infos